Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

Cavé, H; van der Werff ten Bosch, J; Suciu, S; Guidal, C; Waterkeyn, C; Otten, J; Bakkus, M; Thielemans, K; Grandchamp, B; Vilmer, E

doi:10.1056/nejm199808273390904

Public

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

Shared by NobleBlocks on Aug 27, 1998 • 12:00 AM UTC

Authors:

H Cavé

J van der Werff ten Bosch

S Suciu

Abstract

BACKGROUND AND METHODS: The implications of the detection of residual disease after treatment of acute lymphoblastic leukemia (ALL) are unclear. We conducted a prospective study at 11 centers to determine the predictive value of the presence or absence of detectable residual disease at several point...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!